Understand co-occurring disorders
Co occurring disorders treatment with Suboxone means managing both opioid use disorder (OUD) and a mental health condition at the same time. Nearly 21.2 million adults in the United States have a co-occurring mental illness and substance use disorder, highlighting how common dual diagnosis can be (SAMHSA). When you face both opioid dependence and anxiety, depression, mood or psychotic disorders, you need a treatment plan that addresses each condition simultaneously.
Diagnosing co-occurring disorders can be complex. Overlapping symptoms—such as difficulty concentrating, sleep disturbances and mood swings—may mask underlying issues. Without a comprehensive assessment, you might only get partial treatment, which can lead to persistent, severe and treatment-resistant symptoms (NIDA).
To illustrate how different psychiatric conditions affect buprenorphine (the active ingredient in Suboxone) treatment, consider this summary from a 2023 multi-state study of 236,198 people with OUD (PMC):
| Disorder category | Buprenorphine initiation | Discontinuation risk (aHR) |
|---|---|---|
| Anxiety disorders | 29.3%, aRR=1.06 [1.05–1.06] | 1.12 [1.09–1.14] |
| Mood disorders | 25.9%, aRR=0.82 [0.82–0.83] | 1.20 [1.17–1.24] |
| Psychotic disorders | 17.5%, aRR=0.95 [0.94–0.96] | 1.04 [0.96–1.13] |
These figures show that anxiety disorders slightly increase buprenorphine initiation, while mood and psychotic disorders are associated with lower initiation rates and higher discontinuation among those with mood disorders. Comorbid conditions complicate care, making a coordinated, integrated approach essential.
Explore Suboxone basics
Suboxone combines buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist. Buprenorphine stabilizes brain chemistry disrupted by opioid addiction without significant intoxication, while naloxone deters misuse by blocking opioid effects if injected (American Addiction Centers). You typically start Suboxone after 12–24 hours of opioid abstinence to prevent precipitated withdrawal and allow a clinician to adjust dosage for optimal stability.
Key benefits of Suboxone include:
- Reducing cravings and withdrawal symptoms to help you focus on therapy and recovery
- Stabilizing mood and lowering anxiety by acting on μ-opioid receptors (FirePit Health)
- Enabling safer outpatient treatment compared to inpatient detox alone
However, Suboxone carries risks:
- Respiratory depression and overdose if combined with benzodiazepines or alcohol (American Addiction Centers)
- Mild side effects such as headache, nausea or constipation
- Need for careful dose titration to avoid precipitated withdrawal
Understanding these basics prepares you to work effectively with your care team on an integrated Suboxone protocol.
Choose integrated MAT approach
Integrated medication-assisted treatment (MAT) combines Suboxone with counseling, behavioral therapies and coordinated medical care. This holistic model outperforms sequential or siloed approaches, improving substance use outcomes, mental health symptoms, retention, cost-effectiveness and satisfaction (SAMHSA/NCBI).
Why integrated care matters:
- Addresses overlapping symptoms and side effects in real time
- Reduces gaps in communication between mental health and addiction specialists
- Lowers stigma by offering one unified care plan
At Ascend Health, we specialize in comprehensive models like integrated behavioral health and mat services that bring together psychiatrists, addiction counselors and primary care providers. Our dual-diagnosis MAT centers ensure you receive:
- Medical supervision during induction and stabilization
- Psychotherapy tailored to co-occurring disorders
- Regular psychiatric support via suboxone treatment with psychiatric support
You can find different entry points to integrated care:
- Outpatient dual-diagnosis MAT programs at our outpatient dual diagnosis mat program
- Telehealth options through our telehealth dual diagnosis treatment platform
- Virtual support via virtual dual diagnosis mat program
These flexible pathways let you choose the setting that fits your schedule and needs.
Combine therapy and medication
While Suboxone addresses the biological aspects of opioid use disorder, evidence-based therapies target behavioral and emotional components of recovery. Pairing both leads to better engagement, fewer relapses and improved mental health outcomes (NIDA).
Evidence-based therapies
Common approaches include:
- Cognitive behavioral therapy (CBT) to change thought patterns contributing to substance use
- Dialectical behavior therapy (DBT) for emotion regulation and distress tolerance
- Motivational interviewing to strengthen your commitment to change
Customized counseling plans
Your Ascend Health treatment team will create a plan that may combine:
- Individual counseling in a mat program with individual counseling setting
- Group therapy for peer support and shared learning
- Family therapy to rebuild trust and educate loved ones
Trauma-informed approaches
If trauma contributes to your substance use, integrating trauma work is essential. We offer suboxone and trauma therapy integration and trauma informed mat treatment that address PTSD, adverse childhood experiences and complex trauma alongside medication management.
Address medication management
Effective co-occurring disorders treatment with Suboxone requires close monitoring of dosing, interactions and adherence.
Initiation and dosing
- Begin Suboxone when mild to moderate withdrawal symptoms appear
- Typical starting dose is 2–4 mg of buprenorphine, adjusted based on response
- Aim for a maintenance dose that prevents withdrawal for 24 hours
Managing interactions
Suboxone can interact with CNS depressants such as benzodiazepines and alcohol, heightening risk of respiratory depression (SAMHSA). Your provider will:
- Review all medications, including anxiety or depression drugs
- Adjust dosages to minimize adverse effects
- Provide education on safe use
Monitoring adherence
Consistent medication adherence is critical. To support you:
- We use pill counts or pharmacy refill tracking
- Offer counseling on coping strategies to handle cravings
- Provide the option of extended-release Sublocade in sublocade treatment with behavioral therapy if daily dosing poses challenges
Monitor and adjust treatment
Your recovery journey isn’t static. Regular check-ins help your team assess progress and adjust interventions.
Tracking progress
Use validated scales and self-reports to measure:
- Opioid craving intensity
- Anxiety and depression levels
- Quality of life and functioning
Addressing side effects
If you experience side effects—such as sedation or gastrointestinal upset—your provider may:
- Modify the dose or dosing schedule
- Switch to an alternative buprenorphine formulation
- Add supportive medications under careful supervision
When to modify care
Treatment modifications may include:
- Adding or intensifying psychotherapy sessions
- Transitioning to a higher level of care, such as a dual diagnosis mat center
- Incorporating specialized programs like outpatient suboxone program for anxiety or depression and addiction mat program
Leverage support services
Successful recovery often relies on a network of support beyond your core treatment plan.
Peer and community support
- Support groups such as SMART Recovery or Narcotics Anonymous can reinforce coping skills
- Peer recovery coaches share lived experience and accountability
Telehealth and virtual care
Telemedicine expands access to integrated care, allowing you to:
- Attend therapy from home via virtual dual diagnosis mat program
- Receive medication management and therapy in a single session
Multi-disciplinary teams
Your care at Ascend Health includes:
- Addiction specialists and psychiatrists
- Primary care providers and case managers
- Social workers and vocational counselors
This team coordinates services like HIV/hepatitis testing, risk-reduction counseling and referrals, addressing public health needs alongside your treatment (SAMHSA).
Evaluate treatment outcomes
Assessing both short-term and long-term success ensures you stay on track toward sustained recovery.
Measuring success metrics
Key indicators include:
- Reduction in opioid use or negative drug tests
- Improvement in mental health symptom scores
- Enhanced social and occupational functioning
Long-term maintenance
After stabilization, your plan might shift to:
- Tapering Suboxone gradually under clinical supervision
- Continuing periodic therapy sessions
- Engaging in alumni or recovery community activities
Preventing relapse
Relapse prevention strategies cover:
- Identifying and coping with triggers
- Developing a personalized relapse prevention plan
- Accessing 24/7 crisis support from your care team
By understanding co-occurring disorders, exploring Suboxone basics, choosing an integrated MAT approach, combining therapy and medication, managing your medication carefully, monitoring your progress, leveraging support services and evaluating outcomes, you’ll have a clear roadmap to successful co-occurring disorders treatment with Suboxone. Ascend Health stands ready to guide you through each step, offering comprehensive care that addresses both opioid use and mental health—so you can reclaim balance and well-being in your life.
